Advances in Medicinal Chemistry, Volume 4

1st Edition

Editors: B.E. Maryanoff A.B. Reitz
Hardcover ISBN: 9780762300648
eBook ISBN: 9780080526379
Imprint: Elsevier Science
Published Date: 1st April 1999
Page Count: 321
128.00 + applicable tax
78.00 + applicable tax
96.95 + applicable tax
123.00 + applicable tax
Unavailable
Compatible Not compatible
VitalSource PC, Mac, iPhone & iPad Amazon Kindle eReader
ePub & PDF Apple & PC desktop. Mobile devices (Apple & Android) Amazon Kindle eReader
Mobi Amazon Kindle eReader Anything else

Institutional Access


Table of Contents

Preface (B.E. Maryanoff, A.B. Reitz). Novel peptide mimetic building blocks and strategies for efficient lead finding (D. Obrecht et al.). Recent advances in the medicinal chemistry of taxoid anticancer agents (I. Ojima et al.). Synthesis and structure-activity relationships of peroxidic antimalarials based on artemisinin (M.A. Avery et al.). Design of compound libraries for detecting and pursuing novel small molecule leads (A.M. Ferguson, R.D. Cramer). A theoretical model of the human thrombin receptor (PAR-1), the first known protease-activated G-protein-coupled receptor (M.P. Beavers et al.). Farnesyl transferase inhibitors: design of a new class of cancer chemotherapeutic agents (T.M. Williams, C.J. Dinsmore).

Description

Volume 4 of Advances in Medicinal Chemistry is comprised of six chapters on a wide range of topics in medicinal chemistry, including molecular modeling, structure-based drug design, organic synthesis, peptide conformational analysis, biological assessment, structure-activity correlation, and lead optimization. Chapter 1 presents an account about amino acid-based peptide mimetics corresponding to b-turn, loop, helical motifs in proteins as a probe of ligand-receptor and ligand-enzyme molecular interactions. Chapter 2 addresses new facets of the medicinal chemistry of the important anticancer drug Taxol® (paclitaxel). Chapter 3 relates an account of the search for new drugs for the treatment of malaria based on the natural product artemisinin. Chapter 4 applies computational chemistry to the evaluation of compound libraries for biological testing. Chapter 5 describes the construction of a 3-dimensional molecular model of the human thrombin receptor, the first protease-activated G-protein coupled receptor (PAR-1), as a means to explore the intermolecular contacts involved in agonist peptide recognition. Finally, Chapter 6 describes the research conducted at Merck on inhibitors of farnesyl transferase as a potential treatment for human cancers.

Readership

For students, researchers and industrialists in the field of medicinal chemistry


Details

No. of pages:
321
Language:
English
Copyright:
© Elsevier Science 1999
Published:
Imprint:
Elsevier Science
eBook ISBN:
9780080526379
Hardcover ISBN:
9780762300648

Reviews

Volume 4 of Advances in Medicinal Chemistry is comprised of six chapters on a wide range of topics in medicinal chemistry, including molecular modeling, structure-based drug design, organic synthesis, peptide conformational analysis, biological assessment, structure-activity correlation, and lead optimization. Chapter 1 presents an account about amino acid-based peptide mimetics corresponding to b-turn, loop, helical motifs in proteins as a probe of ligand-receptor and ligand-enzyme molecular interactions. Chapter 2 addresses new facets of the medicinal chemistry of the important anticancer drug Taxol® (paclitaxel). Chapter 3 relates an account of the search for new drugs for the treatment of malaria based on the natural product artemisinin. Chapter 4 applies computational chemistry to the evaluation of compound libraries for biological testing. Chapter 5 describes the construction of a 3-dimensional molecular model of the human thrombin receptor, the first protease-activated G-protein coupled receptor (PAR-1), as a means to explore the intermolecular contacts involved in agonist peptide recognition. Finally, Chapter 6 describes the research conducted at Merck on inhibitors of farnesyl transferase as a potential treatment for human cancers.


About the Editors

B.E. Maryanoff Editor

Affiliations and Expertise

Drug Discovery, R.W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania, USA

A.B. Reitz Editor

Affiliations and Expertise

Drug Discovery, R.W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania, USA